Involvement of Bax protein in the prevention of glucocorticoid-induced thymocytes apoptosis by melatonin

Publication date

2022-06-14T15:50:50Z

2022-06-14T15:50:50Z

2004-01

2022-06-14T15:50:51Z

Abstract

The antiapoptotic effect of melatonin has been described in several systems. In this study, the antagonistic effect of the methoxyindole on dexamethasone-induced apoptosis in mouse thymocytes was examined. Melatonin decreased both DNA fragmentation, and the number of annexin V-positive cells incubated in the presence of dexamethasone. Analysis of the expression of the members of the Bcl-2 family indicated that the synthetic glucocorticoid increased Bax protein levels without affecting the levels of Bcl-2, Bcl-XL, Bcl-XS, or Bak. This effect correlated with an increase in thymocytes bax mRNA levels. Dexamethasone also increased the release of cytochrome C from mitochondria. All of these effects were reduced in the presence of melatonin, which was ineffective per se on these parameters. In addition, the involvement of cAMP on glucocorticoid/melatonin antagonism was examined. Both melatonin and dexamethasone decreased the levels of this nucleotide in mouse thymocytes, indicating that the antagonistic action between both hormones involves a cAMP-independent pathway. In summary, the present results suggest that the antiapoptotic effect of melatonin on glucocorticoid-treated thymocytes would be a consequence of an inhibition of the mitochondrial pathway, presumably through the regulation of Bax protein levels.

Document Type

Article


Published version

Language

English

Publisher

Association for the Study of Internal Secretions

Related items

Reproducció del document publicat a: https://doi.org/10.1210/en.2003-0764

Endocrinology, 2004, vol. 145, num. 1, p. 418-425

https://doi.org/10.1210/en.2003-0764

Recommended citation

This citation was generated automatically.

Rights

(c) Association for the Study of Internal Secretions, 2004

This item appears in the following Collection(s)